reviewed to identify patient demographics, perioperative characteristics, complications within 60 days, and short term surgical outcomes. Complications were graded using the Clavien system and those with a grade ¼ 3 were classified as major complications.
INTRODUCTION AND OBJECTIVES:
To investigate a potential link between the development of systemic/autoimmune disorders and synthetic polypropylene mesh repairs.
METHODS: New York State Department of Health Statewide Planning and Research Cooperative System data was utilized to conduct this retrospective cohort study. Adult women undergoing surgery for pelvic organ prolapse (POP) with vaginally implanted mesh between January 2008 and December 2009 in inpatient and ambulatory surgery settings in New York State were identified. Two separate control cohorts were created with whom to compare outcomes, including a colonoscopy cohort and a vaginal hysterectomy cohort (without POP repair or sling). Patients in the mesh cohort were individually matched to the control cohorts based on demographics, comorbidities and procedure date. The development of systemic/autoimmune disease was determined before and after matching for 6-month, 1-year, 2-year and entire follow-up (up to 5 years until December 2014) and differences between groups were evaluated.
RESULTS: A total of 2,257 patients underwent mesh based POP surgery between January 2008 and December 2009. In the control cohorts, 114,399 patients underwent colonoscopy and 9,395 underwent vaginal hysterectomy. When patients were matched based on demographics, comorbidities and procedure time, mesh-based surgery was not associated with an increased risk of developing autoimmune disease at any of the evaluated time periods.
CONCLUSIONS: Mesh-based vaginal surgery was not associated with the development of systemic/ autoimmune diseases. This data refutes claims against mesh as a cause of systemic disease.
Source of Funding: Funded from American Urological Association Data Grant Program

PD17-09 FIVE-YEAR EXPERIENCE WITH PELVIC FLOOR MESH EXPLANT SURGERY: PATIENT CHARACTERISTICS AND PATIENT REPORTED OUTCOMES
Elliot Blau*, Sarah Adelstein, Alvaro Lucioni, Kathleen Kobashi, Una Lee, Seattle, WA INTRODUCTION AND OBJECTIVES: Complications related to mesh implants for pelvic organ prolapse or incontinence are an important and controversial issue. However, there is limited literature on preoperative factors and outcomes of patients undergoing mesh removal. We present our experience with pelvic floor mesh explant surgery at a tertiary referral center. We aim to evaluate patient characteristics in an effort to identify factors that could predispose patients to mesh complications and assess patient reported outcomes to determine if preexisting symptoms successfully abate following mesh removal.
METHODS: This is a retrospective case series of consecutive patients undergoing removal of mesh graft for treatment of symptomatic mesh related complications from 2011-16. Cases were identified by CPT codes 57287, 57295 and 57296. Patient demographics, comorbidities, symptoms and mesh factors were evaluated. Patient reported outcomes were determined by validated self-assessment instruments: patient global impression of improvement (PGI-I) and Likert satisfaction scale (0-10).
RESULTS: 147 symptomatic patients underwent complete or partial pelvic floor mesh removal by 3 subspecialized urologists. Results and presenting symptoms are summarized in Table 1 . Associated comorbidities include prior or current tobacco use, psychiatric disease, chronic pain, irritable bowel syndrome and fibromyalgia. 80% of patients reported pain. Mesh exposure or erosion was identified in 83% of patients. Mid urethral sling comprised 86% of explanted mesh grafts. At mean follow up of 14 months, 68% reported improvement after surgery (PGI-I mean 2.9, SD AE 1.68) and were satisfied (Likert score mean 7.4, SD AE 3).
CONCLUSIONS: Excision of symptomatic mesh implants can successfully improve presenting symptoms and bother based on e356 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 
